drugset / Trial / NCT01559727

Dose-comparison Study of Prednisone in Heart Failure

NCT01559727 ↗

Phase 3 Completed 40 enrolled Hebei Medical University
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to examine the efficacy of three doses of prednisone, a glucocorticoid, in treatment of patients with symptomatic heart failure.

Timeline

Start
2012-03
Primary completion
2013-01
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Prednisone Other / unclassified 15 mg —
Subject Prednisone Other / unclassified 30 mg —
Subject Prednisone Other / unclassified 60 mg —